MALIGNANT HYPERTHERMIA

  •  

    DEFINITION:

    An acute potentially fatal metabolic disorder characterized by acute hypercatabolic reactions in muscles in response to specific triggering factors.

    EPIDEMIOLOGY:

    • incidence: 1/12-15,000 children (greater than in adults)
    • age of onset:
      • ?
    • risk factors:
      • familial - autosomal dominant, autosomal recessive, and multigenic inheritence pattern
      • chrom. #: 19q13.1
      • gene: ryanodine receptor (RYR1)
    • M > F
    • associations:
      • Central Core Disease
      • DMD
      • King Syndrome
      • SIDS
      • Evan Syndrome
      • osteogenesis imperfecta

    PATHOGENESIS:

    1. Etiology

    • triggering agents:
  • 1. Drugs
    • inhalational agents
      • halothane
    • depolarizing skeletal muscle relaxants
      • succinylcholine
  • 2. Stressors
    • physical
    • emotional
    • triggering agent -> exaggerated release of calcium from the SR -> sudden rise of intracellular calcium -> hypermetabolic state characterized by:
      • increased conversion of phosphorylase b -> a
      • stimulation of glycolysis
      • hydrolysis of ATP
      • uncoupling of oxidative phosphorylation
    • the exaggerated release of calcium seems to be the primary defect and may be related to a mutation in the ryanodine receptor (RYR) gene (Ca-release channel of the sarcoplamic reticulum) resulting in an unusually high sensitivity to calcium augmented by caffeine

    NOTES:

    • clinical features of patients with succinylcholine-induced muscle rigidity:
      • succinylcholine used for intubation
      • halothane used for induction
      • age range: 4 - 15 years (mean 10 years)
      • temperature increases not marked
      • significant arrhythmias not noted
      • muscle rigidity lasts for only 2-3 minutes
      • family history of MH generally not found
      • if perioperative CK conc. > 20,000 -> usually + muscle biopsy
      • dd: dystrophia myotonica, myotonia contenita

    CLINICAL FEATURES:

    1. Early

    • sinus tachycardia
    • fever (> 41 C) - variable (minutes -> usually hours)
    • rigidity - masseter jaw spasm -> generalized
    • unstable BP - with upward trend
    • tachypnea
    • skin changes - sweating/flushing/mottled cyanosis
    • ventricular arrhythmias - extrasystole -> bigeminy -> VT

    2. Late

    • encephalopathy with cerebral edema
    • pulmonary edema
    • renal failure
    • consumption coagulopathy (DIC)
    • skeletal muscle edema and pain
    • increased danger of relapse for 3 days post crisis even without exposure to triggering agents

    INVESTIGATIONS:

    1. Diagnosis

    1. Muscle Biopsy

    • in vitro contraction test
    • caffeine-halothane contracture
      • caffeine - increased resting tension with incremental doses
      • halothane - contraction of several minutes duration

    2. Polymerase Chain Reaction

    • ?

    2. Respiratory

    • rising PECO2 - earliest observable sign
    • oxygenation - normal PaO2 but decreased PvO2

    3. Metabolic

    • acidosis - both respiratory and metabolic (lactic)
    • potassium - initally increased then prolonged decrease
      • rebound hyperkalemia 6-12 hours
    • electrolytes
      • calcium - initally increased -> prolonged decrease for days
      • PO4, Mg - persistent increase
    • glucose - persistent increase

    4. Muscle

    • CPK - persistent elevation (peak at 12-24 hours)
    • myoglobin - myoglobinemia -> -uria -> increased BUN

    MANAGEMENT:

    • stop trigger - halothane, succinylcholine
    • hyperventilate - to correct respiratory acidosis
    • dantrolene - acts directly on the SR to increase contraction activation threshold -> prevents depolarization
    • initally 2.5 mg/kg IV
    • if symptoms persist after 45 min -> 7.5 mg/kg
    • continuously until crisis resolves - 2.5 mg/kg q6H
    • supportive - correct metabolic acidosis - HCO3
      • treat arrhythmias
      • control temperature - cooling
    • moniter - lytes, Ca, Mg, PO4, glucose, lactate, BUN
      • muscle enzymes: CPK, LDH, AST, aldolase

     

     

    Pediatric Database - MALIGNANT HYPERTHERMIA

    Pediatric Organization - Pedbase [at] Gmail.com